XML 57 R36.htm IDEA: XBRL DOCUMENT v3.25.4
Revenue (Tables)
 12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table presents the approximate percentage of our net sales by market group:
202520242023
Biologics40%39%37%
Generics17%17%20%
Pharma24%25%24%
Contract-Manufactured Products19%19%19%
100%100%100%
The following table presents the approximate percentage of our net sales by product category:
202520242023
High-Value Product Components47%45%50%
High-Value Product Delivery Devices13%14%10%
Standard Packaging 21%22%21%
Contract-Manufactured Products19%19%19%
100%100%100%
Due to the Company's reassessment of product categories, beginning in the second quarter of 2023, certain product types have been moved from High-Value Product Components to High-Value Product Delivery Devices. No adjustments were made to the product categorization prior to and since the second quarter of 2023.
The following table presents the approximate percentage of our net sales by geographic location:
202520242023
Americas46%45%45%
Europe, Middle East, Africa45%46%46%
Asia Pacific9%9%9%
100%100%100%
Schedule of Change in Contract with Customer, Asset and Liability
The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:
($ in millions)
Contract assets, December 31, 2024
$23.3 
Contract assets, December 31, 2025
11.9 
Change in contract assets - (decrease) increase$(11.4)
Deferred income, December 31, 2024
$(53.2)
Deferred income, December 31, 2025
(53.7)
Change in deferred income - (increase) decrease$(0.5)